-
Mashup Score: 1About - Event Page | The State of Biotech 2023 - 9 month(s) ago
Despite the tough market conditions for the industry over the past 2–3 years, the biotechnology sector is poised for big things moving forward. Exciting advances in precision genome editing, cell therapy, synthetic biology, organs-on-chips, next-gen sequencing and artificial intelligence all bode well for the development of new therapies and the health of patients and the industry. In The State…
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1About - Event Page | The State of Biotech 2023 - 9 month(s) ago
Despite the tough market conditions for the industry over the past 2–3 years, the biotechnology sector is poised for big things moving forward. Exciting advances in precision genome editing, cell therapy, synthetic biology, organs-on-chips, next-gen sequencing and artificial intelligence all bode well for the development of new therapies and the health of patients and the industry.
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet-
Registration is open for The State of Biotech 2023! Join us for the virtual event of the year feat. Nobel Laureate Carolyn Bertozzi, Daphne Zohar, Rodolphe Barrangou, & more. And the best part? It's free! @CarolynBertozzi @daphnezohar @CRISPRchef @Cytiva https://t.co/vGTKnxBT4b https://t.co/EP4UpHmCnP
-
-
Mashup Score: 3About - Event Page | The State of Biotech 2023 - 9 month(s) ago
Despite the tough market conditions for the industry over the past 2–3 years, the biotechnology sector is poised for big things moving forward. Exciting advances in precision genome editing, cell therapy, synthetic biology, organs-on-chips, next-gen sequencing and artificial intelligence all bode well for the development of new therapies and the health of patients and the industry.
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2About - Event Page | THE STATE OF PRECISION MEDICINE - 1 year(s) ago
A quarter of a century has passed since the development of pioneering gene-targeted anti-cancer drugs like Herceptin and Gleevec. Since then, we have witnessed many more drug approvals in precision medicines, spanning a wide range of therapeutic indications. In addition, the irrefutable power of precision medicine has been demonstrated with the many stories of patients ret
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0About - Event Page | THE STATE OF PRECISION MEDICINE - 1 year(s) ago
A quarter of a century has passed since the development of pioneering gene-targeted anti-cancer drugs like Herceptin and Gleevec. Since then, we have witnessed many more drug approvals in precision medicines, spanning a wide range of therapeutic indications. In addition, the irrefutable power of precision medicine has been demonstrated with the many stories of patients ret
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0About - Event Page | THE STATE OF PRECISION MEDICINE - 1 year(s) ago
A quarter of a century has passed since the development of pioneering gene-targeted anti-cancer drugs like Herceptin and Gleevec. Since then, we have witnessed many more drug approvals in precision medicines, spanning a wide range of therapeutic indications. In addition, the irrefutable power of precision medicine has been demonstrated with the many stories of patients ret
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0All the deets - Event Page | Fertility Rally Live Spring 2023 - 1 year(s) ago
As the creators of Fab Fertility, Infertile AF, and the Fertility Rall
Source: AcceleventsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0About - Event Page | The STATE of GENOMICS & NGS - 1 year(s) ago
On February 28, 1953, building on the unpublished experimental data of Rosalind Franklin, Francis Crick and James Watson revealed the iconic structure of the DNA double helix, a landmark event in the history of science. Many milestones have been celebrated over the ensuing 70 years, including the Human Genome Project, the tumbling cost of sequencing below $1,000, and just last year, the finish
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0About - Event Page | The STATE of GENOMICS & NGS - 1 year(s) ago
On February 28, 1953, building on the unpublished experimental data of Rosalind Franklin, Francis Crick and James Watson revealed the iconic structure of the DNA double helix, a landmark event in the history of science. Many milestones have been celebrated over the ensuing 70 years, including the Human Genome Project, the tumbling cost of sequencing below $1,000, and just last year, the finish
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0About - Event Page | The STATE of GENOMICS & NGS - 1 year(s) ago
On February 28, 1953, building on the unpublished experimental data of Rosalind Franklin, Francis Crick and James Watson revealed the iconic structure of the DNA double helix, a landmark event in the history of science. Many milestones have been celebrated over the ensuing 70 years, including the Human Genome Project, the tumbling cost of sequencing below $1,000, and just last year, the finish
Source: AcceleventsCategories: Future of Medicine, Latest HeadlinesTweet
Registration is open for The State of Biotech 2023! Join us for the virtual event of the year feat. Nobel Laureate Carolyn Bertozzi, Daphne Zohar, Rodolphe Barrangou, & more. And the best part? It's free! @CarolynBertozzi @daphnezohar @CRISPRchef @Cytiva https://t.co/tKEMH2t4Gm https://t.co/asC2X5LYQF